The Venter Lab retweeted
In spite of the global crisis of #AMR, another pharmaceutical company abandons antibacterial drug development. We need alternative models to fund such programs and support for researchers at academic institutions working on anti-bacterials.
Johnson & Johnson stops development of all antibacterial programs. Sigh!
J&J developed Levaquin, bedaquiline, and several other life-saving antibiotics.
Obviously this happens because they can't make money on antibiotics. Thi…lnkd.in/eSQgfX-t lnkd.in/eK-3RuP4
The Venter Lab retweeted
#Antibiotic R&D pipeline remains insufficient to tackle the growing spread of #AntibioticResistance & #access to treatments is still a challenge...😔
Latest @WHO report highlighting the progress but also the remaining gaps 👇
who.int/news/item/15-05-2023…
#PowerOfAntibiotics
The Venter Lab retweeted
Antibiotic-resistant infections caused 5 million deaths in 2019. In 2020, hospital-onset #AMR infections and deaths jumped 15%. In 2023, superbug outbreaks have gripped our attention. The time to act is now @CentreImpactAMR @WHO workingtofightamr.org/2023/0…





